FormDSignal
45

CollPlant Biotechnologies closes $9.25M raise in Israel-based biotech

Company raise · Closed · Rehovot, Ireland · Form D filed 2026-10-22

CollPlant Biotechnologies Ltd, an Israeli health care company, closed a $9.25M offering under Regulation D exemption 6(b) with five investors. The offering closed on October 9, 2026, with H.C. Wainwright and Rodman & Renshaw serving as placement agents.

Note: Israeli-incorporated company; filing shows closed offering with zero remaining amount and five investors.

Placement agent engagedother

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

Yehiel TalChief Executive Officer and Interim Chairman of the Board of Directors
Eran RotemDeputy Chief Executive Officer and Chief Financial Officer
Oren FahimipoorVice President, Operations
Philippe BensimonVice President, Regulatory Affairs and Quality Assurance
Jasmine SerorVice President, Product Development
Bowman BagleyVice President, Commercial North America
Bar AbelisVice President, Legal
Ruti Ben ShlomiChief Executive Officer of Lightsolver Ltd., the Issuer's subsidiary.
Abraham HavronDirector
Elan PennDirector
Joseph ZarzewskyDirector
Hugh EvansDirector
Alisa LaskDirector

Signed by Eran Rotem, Deputy Chief Executive Officer and Chief Financial Officer.

Placement agents / sales compensation: H.C. Wainwright & Co., LLC; Rodman & Renshaw, LLC

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer